Chao Li, MD
Dermatology · Mesa, AZNPI 1962729160
Payments from drug & device makers
Across 85 payments — averaging $34.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Icotec Medical Inc.$2K
- Dermavant Sciences, Inc.$255
- Amgen$217
- AbbVie$100
- Organon$99
- Pfizer$96
- plus $536 from 16 others
What the payments were for
- Travel & lodging$1,10038%
- Food & beverage$1,80662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Icotec Medical Inc. | 8 | $1,602 |
| Dermavant Sciences, Inc. | 22 | $255 |
| Amgen | 10 | $217 |
| AbbVie | 6 | $100 |
| Organon | 8 | $99 |
| Pfizer | 5 | $96 |
| Sanofi | 3 | $83 |
| Lilly USA, LLC | 3 | $71 |
| Arcutis Biotherapeutics, Inc. | 3 | $63 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $57 |
| Novartis | 2 | $38 |
| Biofrontera Inc. | 1 | $37 |
| Bristol Myers Squibb | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Journey Medical Corporation | 1 | $20 |
| Merz North America, Inc. | 1 | $18 |
| EPI Health, LLC | 1 | $18 |
| Incyte Corporation | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Dermira, Inc. | 1 | $14 |
How this compares
$2,906 in reported general payments places this provider in the 50th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 111 | $4,519 |
| Metronidazole | 48 | $1,631 |
| Triamcinolone Acetonide | 167 | $1,555 |
| Minocycline Hcl | 73 | $1,227 |
| Imiquimod | 43 | $1,209 |
| Ketoconazole | 60 | $1,198 |
| ValacyclovirValacyclovir Hcl | 47 | $873 |
| Fluocinolone Acetonide | 15 | $806 |
| Clindamycin Phosphate | 33 | $771 |
| Mupirocin | 81 | $629 |
| Doxycycline Hyclate | 41 | $607 |
| Betamethasone Dipropionate | 16 | $591 |
| Minoxidil | 80 | $375 |
| Terbinafine Hcl | 43 | $256 |
| Clindamycin Hcl | 20 | $141 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Mesa
- Ronald GlickMesa$91K
- Zainab RashidMesa$14K
- Kenneth SteilPhoenix$15.6M
- Lindsay AckermanPhoenix$7.4M
- Sadra JazayeriPhoenix$5.2M
- Aaron MangoldScottsdale$4.9M
- James PehoushekGlendale$4.8M
- Carsten HamannPhoenix$1.7M
- Dathan HamannPhoenix$1.6M
- Anthony NuaraScottsdale$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.